vidarabine phosphate has been researched along with Ovarian Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Copeland, LJ; Gershenson, DM; Kavanagh, JJ; Saul, P; Stringer, CA | 1 |
| Ajani, JA; Baker, FL; Gershenson, D; Kavanagh, JJ; Spitzer, G; Thielvoldt, D; Tomasovic, B | 1 |
| Alberts, DS; Hutton, JJ; Kronmal, R; O'Toole, RV; Surwit, EA; Von Hoff, DD | 1 |
3 other study(ies) available for vidarabine phosphate and Ovarian Neoplasms
| Article | Year |
|---|---|
Phase II trial of fludarabine in patients with epithelial ovarian cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Arabinonucleotides; Drug Evaluation; Female; Humans; Middle Aged; Ovarian Neoplasms; Vidarabine Phosphate | 1986 |
Activity of 2-fluoro-Ara AMP against gynecologic tumors in the soft agar assay.
Topics: Agar; Arabinonucleotides; Bone Marrow Cells; Cisplatin; Clone Cells; Colony-Forming Units Assay; Culture Media; Culture Techniques; Doxorubicin; Female; Genital Neoplasms, Female; Humans; Ovarian Neoplasms; Vidarabine Phosphate | 1986 |
Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced ovarian cancer. A Southwest Oncology Group Study.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents; Arabinonucleotides; Drug Evaluation; Female; Humans; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Vidarabine Phosphate | 1988 |